Related Experiment Video
Updated: Apr 6, 2026

06:11
Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
2.8K
Rapid and fully automated bacterial pathogen detection on a centrifugal-microfluidic LabDisk using highly sensitive
G Czilwik1, T Messinger, O Strohmeier
1Hahn Schickard, Georges-Koehler-Allee 103, 79110 Freiburg, Germany. Gregor.Czilwik@Hahn-Schickard.de.
Lab on a Chip
|August 4, 2015
Summary
A novel LabDisk system enables rapid, highly-sensitive bacterial pathogen detection within hours. This point-of-care molecular diagnostic tool simplifies workflows for timely antimicrobial treatment decisions.
Area of Science:
- Clinical Microbiology
- Molecular Diagnostics
- Biotechnology
Background:
- Culture-based bacterial identification is slow, delaying targeted antimicrobial therapy.
- Existing rapid molecular diagnostics often involve complex workflows and equipment, limiting routine clinical use.
Purpose of the Study:
- To develop a rapid, sensitive, and user-friendly molecular diagnostic platform for bacterial pathogen detection at the point-of-care.
- To automate integrated DNA extraction, PCR pre-amplification, and real-time PCR on a single device.
Main Methods:
- Development of a centrifugal-microfluidic LabDisk system with pre-stored reagents.
- Fully automated workflow including DNA extraction, consensus multiplex PCR, and species-specific real-time PCR.
- Minimal hands-on time (approx. 5 minutes) for sample and reagent loading.
Main Results:
- Detection of low colony-forming units (cfu) of key bacterial pathogens (e.g., Staphylococcus warneri, Escherichia coli) in serum samples.
- Achieved a complete "sample-to-result" turnaround time of 3 hours and 45 minutes.
- Demonstrated high sensitivity and specificity for multiple bacterial species.
Conclusions:
- The LabDisk system offers a simplified, automated solution for rapid bacterial pathogen detection.
- This point-of-care platform can significantly reduce diagnostic turnaround times in clinical microbiology.
- Enables faster, evidence-based antimicrobial treatment decisions, improving patient outcomes.

